Effects of an 11 <i>β</i> ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome - Concepedia

Concepedia

Publication | Closed Access

Effects of an 11 <i>β</i> ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome

157

Citations

15

References

2011

Year

P. U. Feig, Sukrut Shah, Anne Hermanowski‐Vosatka, D. Plotkin, Martin S. Springer, Steven Donahue, Chau Thach, E. Klein, Eseng Lai, Keith D. Kaufman

Diabetes Obesity and Metabolism

Abstract

Inhibition of HSD1 with MK-0916 was generally well tolerated in patients with T2DM and MetS. Although no significant improvement in FPG was observed with MK-0916 compared to placebo, modest improvements in A1C, body weight and blood pressure were observed.

References

	Year	Citations

Page 1